About Cytrellis
Cytrellis is a company based in Boston (United States) founded in 2012. Cytrellis has raised $111.22 million across 7 funding rounds from investors including Arch Venture Partners, PFM Health Sciences and Sands Capital Ventures. The company has 59 employees as of December 31, 2022. Cytrellis offers products and services including ellacor. Cytrellis operates in a competitive market with competitors including Clearanail, aesthetiCare, Procell Therapies, Dermapen World and Altair Instruments, among others.
- Headquarter Boston, United States
- Employees 59 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cytrellis Biosystems, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$111.22 M (USD)
in 7 rounds
-
Latest Funding Round
$25.13 M (USD), Series C
Dec 20, 2024
-
Investors
Arch Venture Partners
& 6 more
-
Employee Count
59
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cytrellis
Cytrellis offers a comprehensive portfolio of products and services, including ellacor.
System for micro-scale removal of sagging skin.
People of Cytrellis
Unlock access to complete
Unlock access to complete
Funding Insights of Cytrellis
Cytrellis has successfully raised a total of $111.22M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $25.13 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cytrellis
Cytrellis has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Arch Venture Partners, PFM Health Sciences and Sands Capital Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science companies
|
Locked | Locked | Locked | |
|
Healthcare companies are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Growth stage tech & life sciences focused VC Firm investing in Asia and the US
|
Locked | Locked | Locked |
Investor details for Cytrellis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cytrellis
Investment portfolio details for Cytrellis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cytrellis
Detailed financials for Cytrellis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cytrellis Comparisons
Peer comparison for Cytrellis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cytrellis
Cytrellis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clearanail, aesthetiCare, Procell Therapies, Dermapen World and Altair Instruments, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical device for fungal nail treatment is developed.
|
|
| Locked | Locked | Locked |
Developer of tattoo removal pen
|
|
| Locked | Locked | Locked |
Microneedling and dermabrasion systems are developed for aesthetic procedures.
|
|
| Locked | Locked | Locked |
Micro needling products for treating skin conditions are developed.
|
|
| Locked | Locked | Locked |
Offers microdermabrasion machines, wands, and serums for professional skin treatments worldwide.
|
Detailed competitors of Cytrellis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cytrellis
Complete news archive for Cytrellis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cytrellis
Cytrellis was founded in 2012.
Cytrellis is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Cytrellis is a funded company, having raised a total of $111.22M across 7 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Cytrellis is 59.
Cytrellis was founded in 2012 in Boston, United States, as a clinical-stage med-tech company focused on dermatology and aesthetic medicine. A proprietary class of devices is being developed to tighten and manipulate skin without surgery, while sagging skin linked to aging is addressed without incisions or scarring. Operations involve collaboration with physicians and partners to create solutions prioritizing safety, clinical outcomes, and enhanced quality of life for patients.
Cytrellis's top competitors include Dermapen World, Clearanail and aesthetiCare.
Cytrellis offers ellacor.
Cytrellis has 7 investors. Key investors include Arch Venture Partners, PFM Health Sciences, Sands Capital Ventures, PFM Health Sciences, and Merz.